Daniel Tasse

Companies

• DBV TechnologiesBoard member Jan 11, 2021 to now¹
• DBV TechnologiesChief executive officer Jan 11, 2021 to now¹
• REGENXBIO Inc.Board member Aug 16, 2016 to now²
• Bellerophon Therapeutics (United States)Board member Feb 13, 2015 to Jun 25, 2018³
• Keenova Therapeutics plcInterim Pres-Hospital Business May 4, 2015 to May 4, 2015⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RREGENXBIO Inc. RGNX28,861 shares⁵$206.8K at $7.17May 29, 2026
• DBV Technologies DBVT17,094 shares⁶$154.7K at $9.05Mar 8, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• May 29, 2026Granted 9,807 shares of REGENXBIO Inc.⁵
• May 30, 2025Granted 7,768 shares of REGENXBIO Inc.⁷
• May 31, 2024Granted 4,790 shares of REGENXBIO Inc.⁸
• Mar 8, 2024Bought 17,094 shares at $0.83 of DBV Technologies⁶
• Jun 2, 2023Granted 3,486 shares of REGENXBIO Inc.⁹
• Jun 3, 2022Granted 3,010 shares of REGENXBIO Inc.¹⁰